These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [To increase bone density faster and stronger]. MMW Fortschr Med; 2005 May; 147(18):44-5. PubMed ID: 15934589 [No Abstract] [Full Text] [Related]
5. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy. Papapoulos SE Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931 [No Abstract] [Full Text] [Related]
7. [Postmenopausal osteoporosis. Bisphosphonates are not all equal]. MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206 [No Abstract] [Full Text] [Related]
8. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Iwamoto J; Takeda T; Sato Y Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates in the treatment of osteoporosis. Hochberg MC Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):53S-55S. PubMed ID: 9273939 [No Abstract] [Full Text] [Related]
10. [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)]. Adachi JD MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529719 [No Abstract] [Full Text] [Related]
11. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly]. MMW Fortschr Med; 2006 Jun; 148(25):60-1. PubMed ID: 16859169 [No Abstract] [Full Text] [Related]
12. Health-economic comparison of three recommended drugs for the treatment of osteoporosis. Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171 [TBL] [Abstract][Full Text] [Related]
13. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. Hodsman AB; Hanley DA; Josse R CMAJ; 2002 May; 166(11):1426-30. PubMed ID: 12054412 [No Abstract] [Full Text] [Related]
14. [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates]. MMW Fortschr Med; 2005 Apr; 147(14):44. PubMed ID: 15887685 [No Abstract] [Full Text] [Related]
15. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status. Thomson AB; Marshall JK; Hunt RH; Provenza JM; Lanza FL; Royer MG; Li Z; Blank MA; J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894 [TBL] [Abstract][Full Text] [Related]
17. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644 [TBL] [Abstract][Full Text] [Related]